Market revenue in 2024 | USD 367.3 million |
Market revenue in 2030 | USD 518.6 million |
Growth rate | 6% (CAGR from 2025 to 2030) |
Largest segment | Implantable cardioverter defibrillators |
Fastest growing segment | Ventricular Assist Devices |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Ventricular Assist Devices, Implantable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy, Counter Pulsation Devices |
Key market players worldwide | Medtronic PLC, Boston Scientific Corp, Abbott Laboratories, Jarvik Heart, ReliantHeart, Biotronik SE & Co., KG, Berlin Heart GmbH |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to congestive heart failure treatment devices market will help companies and investors design strategic landscapes.
Implantable cardioverter defibrillators was the largest segment with a revenue share of 33.68% in 2024. Horizon Databook has segmented the Germany congestive heart failure treatment devices market based on ventricular assist devices, implantable cardioverter defibrillators, pacemakers, cardiac resynchronization therapy, counter pulsation devices covering the revenue growth of each sub-segment from 2018 to 2030.
As per the Organization for Economic Cooperation, in Germany, more than 310 per 100,000 people die of cardiovascular diseases each year. There are several causes for coronary diseases, including genetics and natural aging, but smoking, obesity, high cholesterol, and diabetes can increase the associated risks.
Thus, there is a high demand for cardiovascular solutions including CHF treatment. With the oldest national social health insurance system, the German healthcare system is considered as the pioneering one in public health support. Moreover, schemes such as statutory health insurance are strengthening the healthcare infrastructure, thus encouraging individuals to undergo advanced treatment.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany congestive heart failure treatment devices market, including forecasts for subscribers. This country databook contains high-level insights into Germany congestive heart failure treatment devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account